Description
RetinAI Discovery is a cloud-based platform that enables automated analysis of ophthalmic imaging data (e.g., OCT, Fundus, FAF). With AI-supported biomarker identification and progression tracking, it empowers clinicians to make faster and more informed decisions in managing retinal diseases.
Key Features:
• Fully automatic AI analysis for OCT and fundus images
• Accurate segmentation of 7 retinal layers & fluid spaces
• Longitudinal progression graphs and biomarker visualization
• SMART Search Engine for patient filtering & clinical trial recruitment
• Fully compliant with GDPR, HIPAA, CE & FDA certifications
Suitable for:
• AMD (incl. GA & nAMD), Diabetic Retinopathy (incl. DME), VM Disorders
• Hospitals, research centers, clinical studies & telemedicine
• Collaborative workflows and data-driven decision-making
Video: RetinAI
